Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: a multicentre study in epilepsy clinics in the United Kingdom (UK).

Introduction: Lacosamide (LCS) is a new antiepileptic drug (AED) licensed in the European Union (EU) and United States (US) in 2008.

Aims: To evaluate the efficacy and tolerability of add-on LCS in an out-patient epilepsy clinic setting to obtain useful information for everyday practice.

Methods: We pooled data retrospectively from the case note of patients with refractory epilepsy in whom LCS had been prescribed in 19 hospitals across the United Kingdom.

Blinded by taboo words in L1 but not L2.

The present study compares the emotionality of English taboo words in native English speakers and native Chinese speakers who learned English as a second language. Neutral and taboo/sexual words were included in a Rapid Serial Visual Presentation (RSVP) task as to-be-ignored distracters in a short- and long-lag condition. Compared with neutral distracters, taboo/sexual distracters impaired the performance in the short-lag condition only.